Current
Neuro-Oncology

Volume 21 Number 7
31 July 2019

Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 7, 31 July

Shah AH, Mahavadi AK, Morell A, Eichberg DG, Luther E, Sarkiss CA, Semonche A, Ivan ME, Komotar RJ.
Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosis.
Neurooncol Pract. 2019 Jul 3, 2020;7(1):94-102∟. doi: 10.1093/nop/npz028∟. PMID: 32257288∟. Observational study. ˍ

Villani V, Pace A, Vidiri A, Tanzilli A, Sperati F, Terrenato I, Mariantonia C, Casini B, Metro G, Maschio M, Tatiana K, Cognetti F, Fabi A.
Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
J Neurooncol. 2019 Jul 4, 2019;144(1):211-216∟. doi: 10.1007/s11060-019-03223-x∟. PMID: 31273578∟. Interventional study. ˍ

Hardian RF, Goto T, Kuwabara H, Hanaoka Y, Kobayashi S, Kanno H, Shimojo H, Horiuchi T, Hongo K.
An autopsy case of widespread brain dissemination of glioblastoma unnoticed by magnetic resonance imaging after treatment with bevacizumab.
Surg Neurol Int. 2019 Jul 5, 2019;10:137∟. doi: 10.25259/SNI-183-2019∟. PMID: 31528472∟. Case report. ˍ

Tien AC, Li J, Bao X, DeRogatis A, Kim S, Mehta S, Sanai N.
A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort.
Clin Cancer Res. 2019 Jul 8, 2019;25(19):5777-5786∟. doi: 10.1158/1078-0432.CCR-19-0133∟. PMID: 31285369∟. Interventional study. ˍ

Giovannini G, Pasini F, Orlandi N, Mirandola L, Meletti S.
Tumor-associated status epilepticus in patients with glioma: Clinical characteristics and outcomes.
Epilepsy Behav. 2019 Jul 9, 2019;101(Pt B):106370∟. doi: 10.1016/j.yebeh.2019.06.014∟. PMID: 31300386∟. Observational study. ˍ

Addeo R, Lamberti G, Simonetti G, Iodice P, Marinelli A, Montella L, Cappabianca S, Gaviani P, Caraglia M, Prete SD, Silvani A.
Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study.
CNS Oncol. 2019 Jul 10, 2019;8(2):CNS32∟. doi: 10.2217/cns-2019-0004∟. PMID: 31290692∟. Observational study. ˍ

Galanis E, Anderson SK, Twohy EL, Carrero XW, Dixon JG, Tran DD, Jeyapalan SA, Anderson DM, Kaufmann TJ, Feathers RW, Giannini C, Buckner JC, Anastasiadis PZ, Schiff D.
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
Cancer. 2019 Jul 10, 2019;125(21):3790-3800∟. doi: 10.1002/cncr.32340∟. PMID: 31290996∟. Interventional study. ˍ

Kameda-Smith MM, Wang A, Abdulhadi N, Voth R, Sergeant A, Maharaj A, Bakhshinyan D, Adile AA, Pai AM, Ajani O, Yarascavitch B, Alyman MC, Duckworth J, Samaan MC, Farrokhyar F, Singh SK, Fleming A; Pediatric Brain Tumour Study Group.
Salvage Therapy for Childhood Medulloblastoma: A Single Center Experience.
Can J Neurol Sci. 2019 Jul 11, 2019;46(4):403-414∟. doi: 10.1017/cjn.2019.39∟. PMID: 31293232∟. Observational study. ˍ

Sharma M, Schilero C, Peereboom DM, Hobbs BP, Elson P, Stevens GHJ, McCrae K, Nixon AB, Ahluwalia MS.
Phase II study of Dovitinib in recurrent glioblastoma.
J Neurooncol. 2019 Jul 11, 2019;144(2):359-368∟. doi: 10.1007/s11060-019-03236-6∟. PMID: 31292802∟. Interventional study. ˍ

Tini P, Nardone V, Pastina P, Marampon F, Sebaste L, Cerase A, Tombolini V, Pirtoli L, Mazzei MA.
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
Clin Neurol Neurosurg. 2019 Jul 15, 2019;184:105445∟. doi: 10.1016/j.clineuro.2019∟.105445. PMID: 31325903∟. Observational study. ˍ

Zhao YY, Chen SH, Hao Z, Zhu HX, Xing ZL, Li MH.
A Nomogram for Predicting Individual Prognosis of Patients with Low-Grade Glioma.
World Neurosurg. 2019 Jul 15, 2019;130:e605-e612∟. doi: 10.1016/j.wneu.2019.06.169∟. PMID: 31319188∟. Observational study. ˍ

Ordookhanian C, Amidon RF, Kaloostian PE.
Gliomatosis Cerebri: A Unique Presentation with Accompanying Clinical Nuance.
Cureus. 2019 Jul 16, 2019;11(7):e5149∟. doi: 10.7759/cureus.5149∟. PMID: 31528509∟. Case report. ˍ

Kumar N, Kumar R, Sharma SC, Mukherjee A, Khandelwal N, Tripathi M, Miriyala R, Oinam AS, Madan R, Yadav BS, Khosla D, Kapoor R.
Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols.
Neurooncol Pract. 2019 Jul 18, 2020;7(1):86-93∟. doi: 10.1093/nop/npz024∟. PMID: 32257287∟. Interventional study. ˍ

Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suvà ML.
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Cell. 2019 Jul 18, 2019;178(4):835-849.e21. doi: 10.1016/j.cell.2019.06.024. PMID: 31327527. ˍ

Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert J, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS.
A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma.
Clin Cancer Res. 2019 Jul 18, 2019;25(19):5799-5807∟. doi: 10.1158/1078-0432.CCR-19-0261∟. PMID: 31320597∟. Interventional study. ˍ

Kaley TJ, Panageas KS, Mellinghoff IK, Nolan C, Gavrilovic IT, DeAngelis LM, Abrey LE, Holland EC, Lassman AB.
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.
J Neurooncol. 2019 Jul 19, 2019 Sep;144(2):403-407∟. doi: 10.1007/s11060-019-03243-7∟. PMID: 31325145∟. Interventional study. ˍ

Fleischmann DF, Unterrainer M, Corradini S, Rottler M, Förster S, la Fougère C, Siepmann T, Schwaiger M, Bartenstein P, Belka C, Albert NL, Niyazi M.
Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
PLoS One. 2019 Jul 24, 2019;14(7):e0216111∟. doi: 10.1371/journal.pone.0216111∟. PMID: 31339892∟. Interventional study. ˍ

Ricard JA, Cramer S, Charles R, Tommee CG, Le A, Bell WR, Chen C, Flanagan ME.
Infratentorial Glioblastoma Metastasis to Bone.
World Neurosurg. 2019 Jul 26, 2019;131:90-94∟. doi: 10.1016/j.wneu.2019.07.142∟. PMID: 31356980∟. Case report. ˍ

Fukuya Y, Ikuta S, Maruyama T, Nitta M, Saito T, Tsuzuki S, Chernov M, Kawamata T, Muragaki Y.
Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas.
J Neurooncol. 2019 Jul 30, 2019;144(3):519-528∟. doi: 10.1007/s11060-019-03250-8∟. PMID: 31363908∟. Observational study. ˍ

Kim D, Wang N, Ravikumar V, Raghuram DR, Li J, Patel A, Wendt RE 3rd, Rao G, Rao A.
Prediction of 1p/19q Codeletion in Diffuse Glioma Patients Using Pre-operative Multiparametric Magnetic Resonance Imaging.
Front Comput Neurosci. 2019 Jul 30, 2019;13:52∟. doi: 10.3389/fncom.2019.00052∟. PMID: 31417387∟. Observational study. ˍ

Valiyaveettil D, Malik M, Joseph DM.
Effect of radiation dose to the periventricular zone and subventricular zone on survival in anaplastic gliomas.
Ecancermedicalscience. 2019 Jul 31, 2019;13:956∟. doi: 10.3332/ecancer.2019.956? PMID: 31645884∟. Observational study. ˍ